OTCMKTS:AOLS Aeolus Pharmaceuticals (AOLS) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChart About Aeolus Pharmaceuticals Stock (OTCMKTS:AOLS) Get Aeolus Pharmaceuticals alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Aeolus Pharmaceuticals, Inc. is a biotechnology company that historically focused on developing medical countermeasures for serious conditions associated with oxidative stress, including injuries caused by radiation, chemical agents and other toxic exposures. The company’s primary investigational product was AEOL 10150, a synthetic catalytic antioxidant designed to mimic certain protective properties of antioxidant enzymes in the body. Aeolus evaluated the compound for potential use in treating pulmonary and other forms of tissue injury, including damage associated with radiation exposure and chemical warfare agents. Aeolus Pharmaceuticals’ development programs were primarily oriented toward government-sponsored preparedness initiatives and specialized therapeutic applications rather than conventional commercial pharmaceutical markets. Publicly available information about its current operations, geographic activities and leadership is limited, and the company’s development status may have changed since its earlier research programs.AI Generated. May Contain Errors. Read More Receive AOLS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aeolus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AOLS Stock News HeadlinesAeolus Pharmaceuticals Inc. (AOLS)May 28, 2026 | nasdaq.comAOLS Aeolus Pharmaceuticals, Inc.August 28, 2024 | seekingalpha.comOminous New Day in America (Get Ready for it)A market forecaster with a 55-year track record - including calls on 1970s double-digit inflation, the 1980s S&L collapse and Black Monday crash, and the 2000s dot-com bust and Lehman Brothers collapse - says a major shift is coming to how Americans bank, work and insure themselves. The New York Times has credited him as the first to spot looming dangers, and he has testified before Congress on past financial crises.October 8 at 1:00 AM | Weiss Ratings (Ad)SDCI.P:CA St. Davids Capital Inc.July 20, 2024 | seekingalpha.comASLN ASLAN Pharmaceuticals LimitedApril 27, 2024 | seekingalpha.comAeolus Tyre Co Ltd (600469)January 12, 2024 | investing.comAeolus: Wind-mapping space laser is losing powerDecember 16, 2023 | bbc.comBAeolus Announces Third Quarter Fiscal Year 2015 Financial ResultsFebruary 21, 2023 | yahoo.comSee More Headlines AOLS Stock Analysis - Frequently Asked Questions How were Aeolus Pharmaceuticals' earnings last quarter? Aeolus Pharmaceuticals Inc. (OTCMKTS:AOLS) posted its quarterly earnings results on Monday, August, 14th. The biopharmaceutical company reported ($0.01) EPS for the quarter. The biopharmaceutical company earned $0.01 million during the quarter. How do I buy shares of Aeolus Pharmaceuticals? Shares of AOLS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Aeolus Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aeolus Pharmaceuticals investors own include Myriad Genetics (MYGN), Nutra Pharma (NPHC), ADOMANI (ADOM), Agritek (AGTK) and Company Calendar Last Earnings8/14/2017Today10/08/2026Fiscal Year End9/30/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:AOLS CIK1261734 Webwww.aeoluspharma.com Phone(949) 481-9825Fax949-481-9829Employees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (OTCMKTS:AOLS) was last updated on 10/8/2026 by MarketBeat.com Staff. From Our PartnersYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredElon’s FINAL Warning? [US Dollar Collapse]On April 25, 2023, Elon Musk issued a stark warning about the future of the US dollar. A former Wall Street...International Living | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | Sponsored"The largest market in human history"SpaceX quietly filed paperwork describing what it calls the largest actionable total addressable market in hum...Behind the Markets | SponsoredA simple options setup that cuts through the noiseIan Cooper says most options traders overcomplicate the process, juggling countless indicators, strategies, an...TradeWins | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredYou ignored me once and it cost you... big time.In 2022, Karim Rahemtulla called Rolls-Royce the best value play in market history. Shares have since climbed ...Monument Traders Alliance | SponsoredHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as Novemeber. It...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aeolus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aeolus Pharmaceuticals With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
